AirSculpt TechnologiesAIRS -1.78%73 OCF Yield % is 2.41 as of Jul. 01, 2026, which is 50% below its 10-year median of 4.83. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.92 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 684 Healthcare Providers & Services companies, AirSculpt Technologies ranks worse than 62.72% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AirSculpt Technologies OCF Yield % Related Terms
AirSculpt Technologies OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, AirSculpt Technologies's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's OCF Yield % distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AirSculpt Technologies (AIRS) has a OCF Yield % of 2.41 as of Jul. 01, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AirSculpt Technologies and its competitors. This is 50% below median its historical median of 4.83. Over the past decade, AirSculpt Technologies' OCF Yield % has ranged from 1.17 to 10.63. According to the industry distribution chart, AirSculpt Technologies ranks #429 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 62.7%.
Is AirSculpt Technologies' OCF Yield % too high?
AirSculpt Technologies' current OCF Yield % of 2.41 is 50% below median its 10-year median of 4.83. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 10.63. The Healthcare Providers & Services industry median OCF Yield % is 5.50. AirSculpt Technologies' value of 2.41 is 56.2% below this industry median. Based on the distribution chart, AirSculpt Technologies ranks #429 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' OCF Yield % compare to AUNA and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #429 out of 684 companies for OCF Yield %. This places AirSculpt Technologies in the lower half of its industry. The industry median OCF Yield % is 5.50. AirSculpt Technologies' value of 2.41 is 56.2% below this benchmark. Historically, AirSculpt Technologies' own OCF Yield % has ranged from 1.17 to 10.63 over the past decade. While the company's 10-year median is 4.83 vs. the industry median of 5.50, AirSculpt Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.50, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AirSculpt Technologies's current OCF Yield % of 2.41 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AirSculpt Technologies and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current OCF Yield % is 2.41, which is 50% below median its own 10-year median of 4.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.92, compared to a current price of $4.41 — trading 12.5% above its estimated fair value. The current OCF Yield % is 2.41, which is 50% below median its 10-year median of 4.83 and 56.2% below the Healthcare Providers & Services industry median of 5.50. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current OCF Yield % is 2.41 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.41 is trading 12.5% above its estimated GF Value™ of $3.92.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
OCF Yield %: 2.41 (50% below median its 10-year median of 4.83)
GF Value™: $3.92 vs. price of $4.41 (12.5% above fair value)
Industry Position: 56.2% below the Healthcare Providers & Services median (#429 of 684)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score
Get the complete analysis for AIRS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 
